FBC
AXDX

Fairfield, Bush & Co’s Accelerate Diagnostics AXDX Stock Holding History

Fairfield, Bush & Co’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,819
Closed -$194K – 151
2020
Q3 		$194K Sell
1,819
-350
-16% -$48.6K 0.06% 142
2020
Q2 		$329K Buy
2,169
+2
+0.1% +$197 0.12% 109
2020
Q1 		$180K Buy
2,167
+350
+19% +$49.2K 0.07% 123
2019
Q4 		$307K Buy
1,817
+743
+69% +$123K 0.11% 115
2019
Q3 		$199K Buy
+1,074
New +$208K 0.07% 143
2018
Q4 		– Sell
-1,029
Closed -$236K – 148
2018
Q3 		$236K Hold
1,029
– – 0.07% 146
2018
Q2 		$229K Hold
1,029
– – 0.07% 149
2018
Q1 		$235K Sell
1,029
-55
-5% -$14.4K 0.07% 146
2017
Q4 		$284K Hold
1,084
– – 0.08% 137
2017
Q3 		$243K Hold
1,084
– – 0.08% 133
2017
Q2 		$296K Hold
1,084
– – 0.09% 120
2017
Q1 		$262K Sell
1,084
-15
-1% -$3.43K 0.08% 128
2016
Q4 		$228K Sell
1,099
-200
-15% -$47.5K 0.07% 132
2016
Q3 		$354K Sell
1,299
-389
-23% -$86.1K 0.11% 114
2016
Q2 		$243K Sell
1,688
-200
-11% -$26.8K 0.08% 121
2016
Q1 		$271K Buy
1,888
+60
+3% +$8.47K 0.1% 112
2015
Q4 		$393K Sell
1,828
-1,880
-51% -$343K 0.14% 105
2015
Q3 		$600K Buy
3,708
+96
+3% +$20.8K 0.26% 67
2015
Q2 		$932K Sell
3,612
-17
-0.5% -$4.06K 0.28% 74
2015
Q1 		$817K Buy
3,629
+119
+3% +$24.9K 0.24% 83
2014
Q4 		$674K Buy
3,510
+82
+2% +$17.6K 0.19% 95
2014
Q3 		$736K Buy
3,428
+665
+24% +$129K 0.21% 91
2014
Q2 		$718K Buy
+2,763
New +$603K 0.21% 92

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Fairfield, Bush & Co's AXDX Position: Q4 2020 in Review

Fairfield, Bush & Co sold out of Accelerate Diagnostics (AXDX) in Q4 2020, closing a stake of 1,819 shares — an estimated $194K sold.

Fairfield, Bush & Co first reported a position in AXDX in Q2 2014 and held it in 23 quarters. The position peaked at $932K in Q2 2015. 115 funds tracked by Wall St. Rank hold AXDX as of Q4 2020.

  • Fairfield, Bush & Co reported no remaining Accelerate Diagnostics position as of Q4 2020 after selling out during the quarter.
  • Fairfield, Bush & Co sold 1,819 Accelerate Diagnostics shares in Q4 2020, an estimated $194K.
  • Fairfield, Bush & Co first reported a position in Accelerate Diagnostics in Q2 2014 and held it in 23 quarters.
  • Fairfield, Bush & Co's Accelerate Diagnostics position peaked at $932K in Q2 2015.
  • 115 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2020.

Based on Fairfield, Bush & Co's 13F filing for Q4 2020, filed 12 Feb 2021.